Heterologous production of dense granule gra7 antigen of toxoplasma gondii in escherichia coli

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 40, Issue 4, 2009, Pages 692-700

  Sadeghiani, Ghazaleh ^a,b   Zare, Mehrak ^a   Babaie, Jalal ^a   Shokrgozar, Mohammad Ali ^a   Azadmanesh, Kayhan ^a   Pezhman, Fard Esfahani ^a   Golkar, Majid ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GRA7 PROTEIN, TOXOPLASMA GONDII; PARASITE ANTIGEN; PROTOZOAL PROTEIN; RECOMBINANT PROTEIN;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BIOSYNTHESIS; ESCHERICHIA COLI; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; TOXOPLASMA;

ANIMALS; ANTIBODY SPECIFICITY; ANTIGENS, PROTOZOAN; ESCHERICHIA COLI; HUMANS; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; TOXOPLASMA;

EID: 68649084277     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Aubert D, Maine GT, Villena I, et al. Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay. J Clin Microbiol 2000; 38: 1144-50.
2. Beghetto E, Spadoni A, Bruno L, Buffolano W, Gargano N. Chimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant products. J Clin Microbiol 2006; 44: 2133-40.
3. Bhopale GM. Development of a vaccine for toxoplasmosis: current status. Microbes Infect 2003; 5: 457-62.
4. Doskaya M, Kalantari-Dehaghi M, Walsh CM, et al. GRA1 protein vaccine confers better immune response compared to codon-opti-mized GRA1 DNA vaccine. Vaccine 2007; 25: 1824-37.
5. Ferrandiz J, Mercier C, Wallon M, Picot S, Cesbron-Delauw MF, Peyron F. Limited value of assays using detection of immunoglobulin G antibodies to the two recombinant dense granule antigens, GRA1 and GRA6 Nt of Toxoplasma gondii, for distinguishing between acute and chronic infections in pregnant women. Clin Diagn Lab Immunol 2004; 11:1016-21.
6. Gatkowska J, Hiszczynska-Sawicka E, Kur J, Holec L, Dlugonska H. Toxoplasma gondii: an evaluation of diagnostic value of recombinant antigens in a murine model. Exp Parasitol 2006; 114: 220-7.
7. Golkar M, Azadmanesh K, Khalili G, et al. Serodi-agnosis of recently acquired Toxoplasma gondii infection in pregnant women using enzyme-linked immunosorbent assays with a recombinant dense granule GRA6 protein. Diagn Microbiol Infect Dis 2008; 61: 31-9.
8. Golkar M, Rafati S, Abdel-Latif MS, et al. The dense granule protein GRA2, a new marker for the serodiagnosis of acute Toxoplasma infection: comparison of sera collected in both France and Iran from pregnant women. Diagn Microbiol Infect Dis 2007a; 58: 419-26.
9. Golkar M, Shokrgozar M A, Rafati S, et al. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice. Vaccine 2007b; 25: 4301-11.
10. Gras L, Gilbert R E, Wallon M, Peyron F, Cortina-Borja M. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect 2004; 132: 541-8.
11. Igarashi M, Kano F, Tamekuni K, et al. Toxoplasma gondii: cloning, sequencing, expression, and antigenic characterization of ROP2, GRA5 and GRA7. Genet Mol Res 2008a; 7: 305-13.
12. Igarashi M, Kano F, Tamekuni K, et al. Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice. Exp Parasitol 2008b; 118: 386-92.
13. Jacobs D, Vercammen M, Saman E. Evaluation of recombinant dense granule antigen 7 (GRA7) of Toxoplasma gondii for detection of immunoglobulin G antibodies and analysis of a major antigenic domain. Clin Diagn Lab Immunol 1999; 6: 24-9.
14. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol 2001; 154: 357-65.
15. Jongert E, De CS, Dewit J, Huygen K. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Parasite Immunol 2007; 29: 445-53.
16. Jongert E, Melkebeek V, De CS, Dewit J, Verhelst D, Cox E. An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs. Vaccine 2008; 26: 1025-31.
17. Li S, Galvan G, Araujo FG, Suzuki Y, Remington JS, Parmley S. Serodiagnosis of recently acquired Toxoplasma gondii infection using an enzyme-linked immunosorbent assay with a combination of recombinant antigens. Clin Diagn Lab Immunol 2000a; 7: 781-7.
18. Li S, Maine G, Suzuki Y, et al. Serodiagnosis of recently acquired Toxoplasma gondii infection with a recombinant antigen. J Clin Microbiol 2000b; 38: 179-84.
19. Liesenfeld O, Press C, Montoya JG, et al. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol 1997; 35:174-8.
20. Martin V, Supanitsky A, Echeverria PC, et al. Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis. Clin Diagn Lab Immunol 2004; 11: 704-10.
21. Mercier C, Adjogble KD, Daubener W, Delauw MF. Dense granules: are they key organelles to help understand the parasitophorous vacuole of all apicomplexa parasites? Int J Parasitol 2005; 35: 829-49.
22. Mevelec MN, Bout D, Desolme B, et al. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plas-mid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine 2005; 23: 4489-99.
23. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363:1965-76.
24. Neudeck A, Stachelhaus S, Nischik N, Striepen B, Reichmann G, Fischer HG. Expression variance, biochemical and immunological properties of Toxoplasma gondii dense granule protein GRA7. Microbes Infect 2002; 4:581-90.
25. Pfrepper KI, Enders G, Gohl M, et al. Sero-reactivity to and avidity for recombinant antigens in toxoplasmosis. Clin Diagn Lab Immunol 2005; 12: 977-82.
26. Pietkiewicz H, Hiszczyn'ska-Sawicka E, Kur J, et al. Usefulness of Toxoplasma gondii recombinant antigens (GRA1, GRA7 and SAG1) in an immunoglobulin G avidity test for the serodiagnosis of toxoplasmosis. Parasitol Res 2006; 100: 333-7.
27. Pietkiewicz H, Hiszczynska-Sawicka E, Kur J, et al. Usefulness of Toxoplasma gondii-speciñc recombinant antigens in serodiagnosis of human toxoplasmosis. J Clin Microbiol 2004; 42:1779-81.
28. Redlich A, Muller WA. Serodiagnosis of acute toxoplasmosis using a recombinant form of the dense granule antigen GRA6 in an enzyme-linked immunosorbent assay. Parasitol Res 1998; 84: 700-6.
29. Remington JS, McLeod R, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious disease of the fetus and newborn infant. Philadelphia, Pa: WB Saunders, 1995; 140-267.
30. Remington JS, Thulliez P, Montoya JG. Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol 2004; 42: 941-5.
31. Van GP, Bosman F, De MF, Van HH, Herion P. Serodiagnosis of toxoplasmosis by using a recombinant form of the 54-kilodalton rhoptry antigen expressed in Escherichia coli. J Clin Microbiol 1993; 31: 9-15.
32. Vercammen M, Scorza T, Huygen K, et al. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun 2000; 68: 38-45.
33. Wilson M, Remington JS, Clavet C, Varney G, Press C, Ware D. Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. The FDA Toxoplasmosis Ad Hoc Working Group. J Clin Microbiol 1997; 35: 3112-5.